First Header Logo Second Header Logo

Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor a-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells.

Nimmanapalli R, Porosnicu M, Nguyen D, Worthington E, O'Bryan E, Perkins C, Bhalla K. Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor a-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells. Clin Cancer Res. 2019 Jul 01; 25(13):4195.

View in: PubMed